Influence of Aldo-keto Reductase 1C3 in Prostate Cancer - A Mini Review

被引：13

作者：

Karunasinghe, Nishi ^{[1
]}

Masters, Jonathan ^{[2
]}

Flanagan, Jack U. ^{[1
]}

Ferguson, Lynnette R. ^{[1
,3
]}

机构：

[1] Univ Auckland, FM&HS, Auckland Canc Soc Res Ctr, Private Bag 92019, Auckland 1142, New Zealand

[2] Auckland Hosp, Urol Dept, Auckland, New Zealand

[3] Univ Auckland, FM&HS, Discipline Nutr & Dietet, Auckland, New Zealand

来源：

CURRENT CANCER DRUG TARGETS | 2017年 / 17卷 / 07期

关键词：

AKR1C3; rs12529; extra-testicular androgen; prostate-specific antigen (PSA); prostate cancer (PC); cancer progression; androgen deprivation therapy (ADT); inhibitors; 5 17-BETA-HYDROXYSTEROID-DEHYDROGENASE AKR1C3; ANDROGEN-DEPRIVATION THERAPY; TYPE-3 3-ALPHA-HYDROXYSTEROID DEHYDROGENASE; STEROIDOGENIC ENZYME AKR1C3; 1 MEMBER C3; ADIPOSE-TISSUE; IN-VITRO; SELECTIVE INHIBITORS; INTRATUMORAL STEROIDOGENESIS; INCREASED EXPRESSION;

D O I：

10.2174/1568009617666170330115722

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Background: Aldo-keto reductase 1C3 (AKR1C3) is an important oxidoreductase with multiple substrates, that are involved in producing extra-testicular androgens. Its activity is influenced by environmental exposures, as well as by genetic variants. These genetic variants could therefore produce variable testosterone levels and subsequent androgen receptor (AR) activation. This could lead to differential downstream production of the prostate-specific antigen (PSA). As PSA level is used for clinical evaluation of the prostate, these variations could impact prostate cancer (PC) diagnosis, as well as PC management outcomes. This review brings together information with regards to key functions of this enzyme, its relevance in PC, its transcriptional regulation, clinical aspects associated with genetics, differential regulation in cancer and cancer progression, and the types of AKR1C3 inhibitors with future therapeutic value. Conclusion: Based on these discussions, hypotheses are forwarded for future applicability of this enzyme and its genetic variants in transformational medical practices in PC. Options for the use of personalised AKR1C3 inhibitor drugs for late stage PC are also discussed.

引用

页码：603 / 616

页数：14

共 143 条

[1] AKR1C3 as a target in castrate resistant prostate cancer [J].

Adeniji, Adegoke O. ;

Chen, Mo ;

Penning, Trevor M. .

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2013, 137 :136-149

[2] Discovery of substituted 3-(phenylamino)benzoic acids as potent and selective inhibitors of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3) [J].

Adeniji, Adegoke O. ;

Twenter, Barry M. ;

Byrns, Michael C. ;

Jin, Yi ;

Winkler, Jeffrey D. ;

Penning, Trevor M. .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (05) :1464-1468

[3] Inherited Variants in SULT1E1 and Response to Abiraterone Acetate by Men with Metastatic Castration Refractory Prostate Cancer [J].

Agarwal, Neeraj ;

Alex, Anitha B. ;

Farnham, James M. ;

Patel, Shiven ;

Gill, David ;

Buckley, Tyler H. ;

Stephenson, Robert A. ;

Cannon-Albright, Lisa .

JOURNAL OF UROLOGY, 2016, 196 (04) :1112-1116

[4] An integrative approach for the identification of prognostic and predictive biomarkers in rectal cancer [J].

Agostini, Marco ;

Janssen, Klaus-Peter ;

Kim, Ll-Jin ;

D'Angelo, Edoardo ;

Pizzini, Silvia ;

Zangrando, Andrea ;

Zanon, Carlo ;

Pastrello, Chiara ;

Maretto, Isacco ;

Digito, Maura ;

Bedin, Chiara ;

Jurisica, Igor ;

Rizzolio, Flavio ;

Giordano, Antonio ;

Bortoluzzi, Stefania ;

Nitti, Donato ;

Pucciarelli, Salvatore .

ONCOTARGET, 2015, 6 (32) :32561-32574

[5] Human Periprostatic Adipose Tissue: its Influence on Prostate Cancer Cells [J].

Alejandra Sacca, Paula ;

Pistone Creydt, Virginia ;

Choi, Hosoon ;

Nestor Mazza, Osvaldo ;

Johanna Fletcher, Sabrina ;

Fernandez Vallone, Valeria Beatriz ;

Scorticati, Carlos ;

Alejandra Chasseing, Norma ;

Carlos Calvo, Juan .

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2012, 30 (01) :113-122

[6] Structures of complexes of type 5 17β-hydroxysteroid dehydrogenase with structurally diverse inhibitors: insights into the conformational changes upon inhibitor binding [J].

Amano, Yasushi ;

Yamaguchi, Tomohiko ;

Niimi, Tatsuya ;

Sakashita, Hitoshi .

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2015, 71 :918-927

[7]

[Anonymous], ABSTR APPL ANAL

[8] Development of prostate cancer in a patient with primary hypogonadism: intratumoural steroidogenesis in prostate cancer tissues [J].

Arai, S. ;

Shibata, Y. ;

Nakamura, Y. ;

Kashiwagi, B. ;

Uei, T. ;

Tomaru, Y. ;

Miyashiro, Y. ;

Honma, S. ;

Hashimoto, K. ;

Sekine, Y. ;

Ito, K. ;

Sasano, H. ;

Suzuki, K. .

ANDROLOGY, 2013, 1 (01) :169-174

[9]

Armstrong CM, 2015, AM J CLIN EXP UROL, V3, P64

[10] Tissue Distribution of Human AKR1C3 and Rat Homolog in the Adult Genitourinary System [J].

Azzarello, Joseph ;

Fung, Kar-Ming ;

Lin, Hsueh-Kung .

JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2008, 56 (09) :853-861

← 1 2 3 4 5 6 7 8 9 10 →